Výsledky vyhledávání - "Annelie J. Vulink"

Three-Year Follow-up of Neoadjuvant Chemotherapy With or Without Anthracyclines in the Presence of DualERBB2Blockade in Patients WithERBB2-Positive Breast Cancer

Autor: Aafke H. Honkoop, Marie-Jeanne T. F. D. Vrancken Peeters, I.A.M. Mandjes, Caroline M.P.W. Mandigers, Irma M. Oving, Annelie J. Vulink, Lidwine W. Tick, Anna van der Voort, Inge Kemper, GS Sonke, Sabine C. Linn, Agnes J. van de Wouw, Mette S. van Ramshorst, Laurence J. C. van Warmerdam, Erik van Werkhoven, Jelle Wesseling

Publikováno v: JAMA Oncology. 7:978

Importance Primary analysis of the TRAIN-2 study showed high pathologic complete response rates after neoadjuvant chemotherapy with or without anthracyclines plus dualERBB2(formerlyHER2) blockade. Objective To evaluate 3-year event-free survival (EFS

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e16df0357573b6ff295eb5171a94c83
https://doi.org/10.1001/jamaoncol.2021.1371

Zobrazit plný text záznamu

Three-year follow-up of neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2-blockade for HER2-positive breast cancer (TRAIN-2): A randomized phase III trial

Autor: Inge Kemper, I.A.M. Mandjes, Agnes J. van de Wouw, Marie-Jeanne T. F. D. Vrancken Peeters, Aafke H. Honkoop, Anna van der Voort, Laurence J. C. van Warmerdam, Caroline M.P.W. Mandigers, Irma M. Oving, Annelie J. Vulink, Sabine C. Linn, Lidwine W. Tick, Mette S. van Ramshorst, Erik van Werkhoven, Jelle Wesseling, Gabe S. Sonke

Publikováno v: Journal of Clinical Oncology. 38:501-501

501 Background: The multicenter phase III TRAIN-2 study showed high pathological complete response (pCR) rates after neoadjuvant chemotherapy with and without anthracylines plus dual HER2-blockade in stage II-III HER2-positive breast cancer patients

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d41ef5beaa2de203d8c493c0193a6527
https://doi.org/10.1200/jco.2020.38.15_suppl.501

Zobrazit plný text záznamu

Preferences to Receive Unsolicited Findings of Germline Genome Sequencing in a Large Population of Cancer Patients

Autor: Roel H. P. Wouters, Petronella O. Witteveen, Joan B. Heijns, Annelien L. Bredenoord, Neeltje Steeghs, Emile E. Voest, Martijn P. Lolkema, D. ten Bokkel Huinink, T. van Voorthuizen, Hester Wessels, H. van Cruijsen, A. M. May, Laurens V. Beerepoot, Annelie J. Vulink, Stefan Sleijfer, Margreet G. E. M. Ausems, Rhodé M Bijlsma

Publikováno v: SSRN Electronic Journal.

Background: In precision medicine, somatic and germline DNA sequencing are essential to make genome-guided treatment decisions in cancer patients. However, it can also uncover unsolicited findings (UFs) in germline DNA that could have a substantial i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::592d8e8102e720950682af6aed7a94a3
https://doi.org/10.2139/ssrn.3300451

Zobrazit plný text záznamu

Pitfalls and limitations of a single-centre, retrospectively derived prognostic score for Phase I oncology trial participants – Reply to Fussenich et al.: A new, simple and objective prognostic score for Phase I cancer patients

Autor: Stan B. Kaye, David Olmos, Carlos Gomez-Roca, Christophe Massard, Rafael Morales-Barrera, Joo Ern Ang, Annelie J. Vulink

Publikováno v: European Journal of Cancer. 48:594-596

David Olmos *, Joo Ern Ang , Carlos Gomez-Roca , Rafael Morales-Barrera , Annelie J. Vulink , Christophe Massard , Stan Kaye , on behalf of the EDDN a Section of Medicine, The Institute of Cancer Research, Sutton, United Kingdom b Drug Development Un

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41c1dd34c4022a16d575debdf80ef059
https://doi.org/10.1016/j.ejca.2011.11.004

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání